It is well known that epithelial-mesenchymal transition (EMT) is necessary for theprogression of several kinds of cancers, including down-regulating the expression of epithelial marker such as N-cadherin, and up-regulating the expression of mesenchymal markers such as E-cadherin and vimentin [31]. This evidence concerns the gene CDH2 and cancer.